We hereby submit the transcript of the earnings conference call for the quarter and year ended March 31, 2023, held on May 20, 2023 at 14.00 Hrs IST. The transcript is also available on the website of the Company i.e. www.divislabs.com, under Investors Relations section.
Conference Call with Divi's Laboratories Ltd. Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: Murali Divi and Senior Team
Further to our intimation letter dated January 25, 2023, we hereby inform that the audio recording of the earnings conference call for the quarter and nine ended December 31, 2022, held on February 03, 2023 at 14.00 Hrs IST has been uploaded on the Company's website at the following weblink: https://www.divislabs.com/wp-content/uploads/2023/02/Earnings-Call-Audio-Q3FY23.mp3
We hereby submit the transcript of the earnings conference call for the quarter and half year ended on September 30, 2022, held on November 07, 2022 at 14.00 Hrs IST. The transcript is also available on the website of the Company i.e. www.divislabs.com, under Investors Relations section.
Further to our intimation letter dated October 28, 2022, we hereby inform that the audio recording of the earnings conference call for the quarter and half year ended September 30, 2022, held on November 07, 2022 at 14.00 Hrs IST has been uploaded on the Company's website at the following weblink: https://www.divislabs.com/wp-content/uploads/2022/11/Earnings-Call-Audio-Q2FY23_07.11.2022.mp3
